The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.


Yilmaz D. , BAYATLI N., UN O., KADOWITZ P., SIKKA S., GUR S.

Urology, cilt.83, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier